Clinical Trials Browser

Recruiting × OTHER_GOV × S 1 (combination) × Clear all

NCT06664021 2025-01-10

Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma